Oral COVID-19 Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 73 pages | ID: O7C8DA13C585EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Oral COVID-19 Drug in global, including the following market information:

Global Oral COVID-19 Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Oral COVID-19 Drug Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Oral COVID-19 Drug companies in 2021 (%)

The global Oral COVID-19 Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oral COVID-19 Drug include Pfizer, MSD and Ridgeback and Shionogi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral COVID-19 Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oral COVID-19 Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oral COVID-19 Drug Market Segment Percentages, by Type, 2021 (%)

• Tablet
• Capsule

Global Oral COVID-19 Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oral COVID-19 Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics

Global Oral COVID-19 Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oral COVID-19 Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oral COVID-19 Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Oral COVID-19 Drug revenues share in global market, 2021 (%)

Key companies Oral COVID-19 Drug sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Oral COVID-19 Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• MSD and Ridgeback
• Shionogi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oral COVID-19 Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oral COVID-19 Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ORAL COVID-19 DRUG OVERALL MARKET SIZE

2.1 Global Oral COVID-19 Drug Market Size: 2021 VS 2028
2.2 Global Oral COVID-19 Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Oral COVID-19 Drug Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Oral COVID-19 Drug Players in Global Market
3.2 Top Global Oral COVID-19 Drug Companies Ranked by Revenue
3.3 Global Oral COVID-19 Drug Revenue by Companies
3.4 Global Oral COVID-19 Drug Sales by Companies
3.5 Global Oral COVID-19 Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Oral COVID-19 Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Oral COVID-19 Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral COVID-19 Drug Players in Global Market
  3.8.1 List of Global Tier 1 Oral COVID-19 Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Oral COVID-19 Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Oral COVID-19 Drug Market Size Markets, 2021 & 2028
  4.1.2 Tablet
  4.1.3 Capsule
4.2 By Type - Global Oral COVID-19 Drug Revenue & Forecasts
  4.2.1 By Type - Global Oral COVID-19 Drug Revenue, 2017-2022
  4.2.2 By Type - Global Oral COVID-19 Drug Revenue, 2023-2028
  4.2.3 By Type - Global Oral COVID-19 Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Oral COVID-19 Drug Sales & Forecasts
  4.3.1 By Type - Global Oral COVID-19 Drug Sales, 2017-2022
  4.3.2 By Type - Global Oral COVID-19 Drug Sales, 2023-2028
  4.3.3 By Type - Global Oral COVID-19 Drug Sales Market Share, 2017-2028
4.4 By Type - Global Oral COVID-19 Drug Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oral COVID-19 Drug Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinics
5.2 By Application - Global Oral COVID-19 Drug Revenue & Forecasts
  5.2.1 By Application - Global Oral COVID-19 Drug Revenue, 2017-2022
  5.2.2 By Application - Global Oral COVID-19 Drug Revenue, 2023-2028
  5.2.3 By Application - Global Oral COVID-19 Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Oral COVID-19 Drug Sales & Forecasts
  5.3.1 By Application - Global Oral COVID-19 Drug Sales, 2017-2022
  5.3.2 By Application - Global Oral COVID-19 Drug Sales, 2023-2028
  5.3.3 By Application - Global Oral COVID-19 Drug Sales Market Share, 2017-2028
5.4 By Application - Global Oral COVID-19 Drug Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Oral COVID-19 Drug Market Size, 2021 & 2028
6.2 By Region - Global Oral COVID-19 Drug Revenue & Forecasts
  6.2.1 By Region - Global Oral COVID-19 Drug Revenue, 2017-2022
  6.2.2 By Region - Global Oral COVID-19 Drug Revenue, 2023-2028
  6.2.3 By Region - Global Oral COVID-19 Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Oral COVID-19 Drug Sales & Forecasts
  6.3.1 By Region - Global Oral COVID-19 Drug Sales, 2017-2022
  6.3.2 By Region - Global Oral COVID-19 Drug Sales, 2023-2028
  6.3.3 By Region - Global Oral COVID-19 Drug Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Oral COVID-19 Drug Revenue, 2017-2028
  6.4.2 By Country - North America Oral COVID-19 Drug Sales, 2017-2028
  6.4.3 US Oral COVID-19 Drug Market Size, 2017-2028
  6.4.4 Canada Oral COVID-19 Drug Market Size, 2017-2028
  6.4.5 Mexico Oral COVID-19 Drug Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Oral COVID-19 Drug Revenue, 2017-2028
  6.5.2 By Country - Europe Oral COVID-19 Drug Sales, 2017-2028
  6.5.3 Germany Oral COVID-19 Drug Market Size, 2017-2028
  6.5.4 France Oral COVID-19 Drug Market Size, 2017-2028
  6.5.5 U.K. Oral COVID-19 Drug Market Size, 2017-2028
  6.5.6 Italy Oral COVID-19 Drug Market Size, 2017-2028
  6.5.7 Russia Oral COVID-19 Drug Market Size, 2017-2028
  6.5.8 Nordic Countries Oral COVID-19 Drug Market Size, 2017-2028
  6.5.9 Benelux Oral COVID-19 Drug Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Oral COVID-19 Drug Revenue, 2017-2028
  6.6.2 By Region - Asia Oral COVID-19 Drug Sales, 2017-2028
  6.6.3 China Oral COVID-19 Drug Market Size, 2017-2028
  6.6.4 Japan Oral COVID-19 Drug Market Size, 2017-2028
  6.6.5 South Korea Oral COVID-19 Drug Market Size, 2017-2028
  6.6.6 Southeast Asia Oral COVID-19 Drug Market Size, 2017-2028
  6.6.7 India Oral COVID-19 Drug Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Oral COVID-19 Drug Revenue, 2017-2028
  6.7.2 By Country - South America Oral COVID-19 Drug Sales, 2017-2028
  6.7.3 Brazil Oral COVID-19 Drug Market Size, 2017-2028
  6.7.4 Argentina Oral COVID-19 Drug Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Oral COVID-19 Drug Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Oral COVID-19 Drug Sales, 2017-2028
  6.8.3 Turkey Oral COVID-19 Drug Market Size, 2017-2028
  6.8.4 Israel Oral COVID-19 Drug Market Size, 2017-2028
  6.8.5 Saudi Arabia Oral COVID-19 Drug Market Size, 2017-2028
  6.8.6 UAE Oral COVID-19 Drug Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Oral COVID-19 Drug Major Product Offerings
  7.1.4 Pfizer Oral COVID-19 Drug Sales and Revenue in Global (2017-2022)
  7.1.5 Pfizer Key News
7.2 MSD and Ridgeback
  7.2.1 MSD and Ridgeback Corporate Summary
  7.2.2 MSD and Ridgeback Business Overview
  7.2.3 MSD and Ridgeback Oral COVID-19 Drug Major Product Offerings
  7.2.4 MSD and Ridgeback Oral COVID-19 Drug Sales and Revenue in Global (2017-2022)
  7.2.5 MSD and Ridgeback Key News
7.3 Shionogi
  7.3.1 Shionogi Corporate Summary
  7.3.2 Shionogi Business Overview
  7.3.3 Shionogi Oral COVID-19 Drug Major Product Offerings
  7.3.4 Shionogi Oral COVID-19 Drug Sales and Revenue in Global (2017-2022)
  7.3.5 Shionogi Key News

8 GLOBAL ORAL COVID-19 DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Oral COVID-19 Drug Production Capacity, 2017-2028
8.2 Oral COVID-19 Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral COVID-19 Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ORAL COVID-19 DRUG SUPPLY CHAIN ANALYSIS

10.1 Oral COVID-19 Drug Industry Value Chain
10.2 Oral COVID-19 Drug Upstream Market
10.3 Oral COVID-19 Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Oral COVID-19 Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Oral COVID-19 Drug in Global Market
Table 2. Top Oral COVID-19 Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Oral COVID-19 Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Oral COVID-19 Drug Revenue Share by Companies, 2017-2022
Table 5. Global Oral COVID-19 Drug Sales by Companies, (K Units), 2017-2022
Table 6. Global Oral COVID-19 Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Oral COVID-19 Drug Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Oral COVID-19 Drug Product Type
Table 9. List of Global Tier 1 Oral COVID-19 Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral COVID-19 Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oral COVID-19 Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Oral COVID-19 Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Oral COVID-19 Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Oral COVID-19 Drug Sales (K Units), 2017-2022
Table 15. By Type - Global Oral COVID-19 Drug Sales (K Units), 2023-2028
Table 16. By Application – Global Oral COVID-19 Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Oral COVID-19 Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Oral COVID-19 Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Oral COVID-19 Drug Sales (K Units), 2017-2022
Table 20. By Application - Global Oral COVID-19 Drug Sales (K Units), 2023-2028
Table 21. By Region – Global Oral COVID-19 Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Oral COVID-19 Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Oral COVID-19 Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Oral COVID-19 Drug Sales (K Units), 2017-2022
Table 25. By Region - Global Oral COVID-19 Drug Sales (K Units), 2023-2028
Table 26. By Country - North America Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Oral COVID-19 Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Oral COVID-19 Drug Sales, (K Units), 2017-2022
Table 29. By Country - North America Oral COVID-19 Drug Sales, (K Units), 2023-2028
Table 30. By Country - Europe Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Oral COVID-19 Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Oral COVID-19 Drug Sales, (K Units), 2017-2022
Table 33. By Country - Europe Oral COVID-19 Drug Sales, (K Units), 2023-2028
Table 34. By Region - Asia Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Oral COVID-19 Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Oral COVID-19 Drug Sales, (K Units), 2017-2022
Table 37. By Region - Asia Oral COVID-19 Drug Sales, (K Units), 2023-2028
Table 38. By Country - South America Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Oral COVID-19 Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Oral COVID-19 Drug Sales, (K Units), 2017-2022
Table 41. By Country - South America Oral COVID-19 Drug Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Oral COVID-19 Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Oral COVID-19 Drug Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Oral COVID-19 Drug Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Oral COVID-19 Drug Product Offerings
Table 48. Pfizer Oral COVID-19 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. MSD and Ridgeback Corporate Summary
Table 50. MSD and Ridgeback Oral COVID-19 Drug Product Offerings
Table 51. MSD and Ridgeback Oral COVID-19 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Shionogi Corporate Summary
Table 53. Shionogi Oral COVID-19 Drug Product Offerings
Table 54. Shionogi Oral COVID-19 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Oral COVID-19 Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 56. Global Oral COVID-19 Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 57. Global Oral COVID-19 Drug Production by Region, 2017-2022 (K Units)
Table 58. Global Oral COVID-19 Drug Production by Region, 2023-2028 (K Units)
Table 59. Oral COVID-19 Drug Market Opportunities & Trends in Global Market
Table 60. Oral COVID-19 Drug Market Drivers in Global Market
Table 61. Oral COVID-19 Drug Market Restraints in Global Market
Table 62. Oral COVID-19 Drug Raw Materials
Table 63. Oral COVID-19 Drug Raw Materials Suppliers in Global Market
Table 64. Typical Oral COVID-19 Drug Downstream
Table 65. Oral COVID-19 Drug Downstream Clients in Global Market
Table 66. Oral COVID-19 Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Oral COVID-19 Drug Segment by Type
Figure 2. Oral COVID-19 Drug Segment by Application
Figure 3. Global Oral COVID-19 Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oral COVID-19 Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oral COVID-19 Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Oral COVID-19 Drug Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oral COVID-19 Drug Revenue in 2021
Figure 9. By Type - Global Oral COVID-19 Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Oral COVID-19 Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Oral COVID-19 Drug Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Oral COVID-19 Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Oral COVID-19 Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Oral COVID-19 Drug Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Oral COVID-19 Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Oral COVID-19 Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Oral COVID-19 Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Oral COVID-19 Drug Sales Market Share, 2017-2028
Figure 19. US Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Oral COVID-19 Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Oral COVID-19 Drug Sales Market Share, 2017-2028
Figure 24. Germany Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Oral COVID-19 Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Oral COVID-19 Drug Sales Market Share, 2017-2028
Figure 33. China Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Oral COVID-19 Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Oral COVID-19 Drug Sales Market Share, 2017-2028
Figure 40. Brazil Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Oral COVID-19 Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Oral COVID-19 Drug Sales Market Share, 2017-2028
Figure 44. Turkey Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Oral COVID-19 Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Oral COVID-19 Drug Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Oral COVID-19 Drug by Region, 2021 VS 2028
Figure 50. Oral COVID-19 Drug Industry Value Chain
Figure 51. Marketing Channels